Skip to content

Magnendo

Magnetically steered robotic guidewires for stroke care

Raised to date

$18M

of $18M offered across 1 Form D filing

Investors
10
Last filed
Jul 29, 2026

About

Magnendo is an MIT spinout developing a robotic navigation system for neurovascular procedures such as stroke thrombectomy and brain aneurysm treatment. Its platform pairs magnetically steerable soft-robotic guidewires with robotic control, medical imaging and navigation software so physicians can reach clots in tortuous brain vasculature faster and more consistently. The technology derives from years of ferromagnetic soft robotics research at MIT, and the team includes engineers and physicians from MIT, Harvard Medical School and Massachusetts General Hospital. The company is preclinical and raised an $18M Series A led by Penumbra, Inc. to productize the platform and prepare first-in-human studies.

Magnetic steering of a soft-robotic guidewire rather than mechanical push-and-torque, which lets the tip navigate complex cerebral vasculature that conventional guidewires cannot reach while reducing the risk of vessel perforation or dissection.

Funding

  • EquityFiled Jul 29, 2026Form D
    $18M/ $18M

Product

Magnendo neurovascular robotic system

Interventional medical robotics

A telerobotic platform combining a magnetically steerable soft-robotic guidewire with robotic actuation, medical imaging and intelligent navigation software for endovascular access to the brain.

  • Magnetically steerable soft-robotic guidewire
  • Robotic, physician-directed telerobotic control
  • Navigation software integrated with medical imaging

Built for

Neurointerventional physicians and the hospitals and comprehensive stroke centers where endovascular thrombectomy and aneurysm procedures are performed

People on file